These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15871360)

  • 1. The efficacy of topical administration of brimonidine to reduce ischaemia in the very early stage of diabetic retinopathy in good controlled type-2 diabetes mellitus.
    Mondal LK; Baidya KP; Bhattacharya B; Chatterjee PR; Bhaduri G
    J Indian Med Assoc; 2004 Dec; 102(12):724-5, 729. PubMed ID: 15871360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
    Wilczyński M; Dzivgielewski K
    Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus.
    Chaturvedi N; Bilous R; Sjolie AK; Klein R;
    Contemp Clin Trials; 2007 Nov; 28(6):780. PubMed ID: 17643353
    [No Abstract]   [Full Text] [Related]  

  • 4. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
    Shimura M; Yasuda K; Shiono T
    Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy.
    Zheng L; Howell SJ; Hatala DA; Huang K; Kern TS
    Diabetes; 2007 Feb; 56(2):337-45. PubMed ID: 17259377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
    Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of complex therapy with emoxipin on the course of diabetic retinopathy].
    Kozlov SA; Khyshiktuev BS; Logunov NA
    Vestn Oftalmol; 2003; 119(2):28-30. PubMed ID: 13678005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus.
    Stolk RP; Vingerling JR; Cruickshank JK; Hughes AD; Stanton A; Juming L; Patel A; Thom SA; Grobbee DE;
    Contemp Clin Trials; 2007 Jan; 28(1):6-17. PubMed ID: 17030155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vision-related quality of life in patients with diabetic macular oedema.
    Hariprasad SM; Mieler WF; Grassi M; Green JL; Jager RD; Miller L
    Br J Ophthalmol; 2008 Jan; 92(1):89-92. PubMed ID: 17584999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual dysfunction after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.
    Shimura M; Yasuda K; Nakazawa T; Tamai M
    Am J Ophthalmol; 2005 Jul; 140(1):8-15. PubMed ID: 15939392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of etofibrate in patients with non-proliferative diabetic retinopathy].
    Emmerich KH; Poritis N; Stelmane I; Klindzane M; Erbler H; Goldsteine J; Görtelmeyer R
    Klin Monbl Augenheilkd; 2009 Jul; 226(7):561-7. PubMed ID: 19644802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of antioxidant therapy for non-proliferative diabetic retinopathy in patients with type 2 diabetes mellitus].
    Alekseev IB; Vorob'eva IV; Mikhaleva LG; Gigineishvili DN; Merkushenkova DA
    Vestn Oftalmol; 2013; 129(6):66-71. PubMed ID: 24624806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
    Adamiec J; Oficjalska-Młyńczak J
    Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ocular manifestations of diabetes: 285 cases].
    Zghal-Mokni I; Nacef L; Letaief I; Mahjoub S; Bouguila H; Blouza S; Jeddi A; Ayed S
    Tunis Med; 2008 Nov; 86(11):1004-7. PubMed ID: 19213494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foveal ganglion cell layer damage in ischemic diabetic maculopathy: correlation of optical coherence tomographic and anatomic changes.
    Byeon SH; Chu YK; Lee H; Lee SY; Kwon OW
    Ophthalmology; 2009 Oct; 116(10):1949-59.e8. PubMed ID: 19699533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic retinopathy and its relevance to paediatric age. An update.
    Porta M; Allione A
    Pediatr Endocrinol Rev; 2004 Jun; 1(4):404-11. PubMed ID: 16437031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A community-based study of the relationship between insulin resistance/beta-cell dysfunction and diabetic retinopathy among type II diabetics in Kinmen, Taiwan.
    Tung TH; Shih HC; Tsai ST; Chou P; Chen SJ; Lee FL; Chuang SY; Liu JH
    Ophthalmic Epidemiol; 2007; 14(3):148-54. PubMed ID: 17613850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
    Zhu H; Shi CH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE; Lai J
    Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
    Hernández M; Urcola JH; Vecino E
    Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.